Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 5Breast 5Head & Neck 3Thoracic 2Other hematologic neoplasm 2Genitourinary 2Gastrointestinal 2Tumor-Agnostic 1Gynecologic 1Dermatologic 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Kidney Calculi 1

Interventions

Magnetic Resonance Spectroscopy 98Specimen Handling 79pembrolizumab 75enzalutamide 63Nivolumab 59Gemcitabine 54Docetaxel 50apalutamide 42Radiosurgery 41Abiraterone Acetate 40Androgen Antagonists 39Prednisone 38Biopsy 37darolutamide 35Cisplatin 35cabozantinib 31Radiotherapy 31Carboplatin 28Pluvicto 27abiraterone 26enfortumab vedotin 24Ipilimumab 24Radiation 23durvalumab 22atezolizumab 22Leuprolide 20olaparib 18X-Rays 18Standard of Care 18avelumab 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Therapeutics × Genitourinary × 90 days × Clear all
NCT07581184 2026-05-12

BActinium-1

Aktis Oncology, Inc.

Phase 1 Recruiting
138 enrolled
Genitourinary

Prostatic Neoplasms

NCT07555756 2026-04-29

An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models

First Affiliated Hospital of Guangxi Medical University

Phase NA Not yet recruiting
1,080 enrolled
Genitourinary

Urinary Bladder Neoplasms, Kidney Calculi, Prostatic Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡